Dmtk th
Web2 days ago · View DermTech, Inc DMTK investment & stock information. Get the latest DermTech, Inc DMTK detailed stock quotes, stock data, Real-Time ECN, charts, stats … WebApr 8, 2024 · finance.yahoo.com - January 10 at 9:15 AM. DermTech Adds Approximately 13 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test …
Dmtk th
Did you know?
WebApr 10, 2024 · DermTech, Inc. (DMTK) In the United States, DMTK, a molecular diagnostic firm, creates and sells cutting-edge non-invasive genomics tests to assist in the detection and treatment of a variety of skin problems, including … WebFind the latest DermTech, Inc. (DMTK) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Web( NASDAQ: DMTK) forecast ROE is -40.15%, which is considered weak. What is DMTK's Price Target? According to 3 Wall Street analyst s that have issued a 1 year DMTK price target, the average DMTK price target is $5.67, with the highest DMTK stock price forecast at $6.00 and the lowest DMTK stock price forecast at $5.00. WebApr 6, 2024 · According to the issued ratings of 5 analysts in the last year, the consensus rating for DermTech stock is Moderate Buy based on the current 1 hold rating and 4 buy ratings for DMTK. The average twelve-month price prediction for DermTech is $10.00 with a high price target of $23.00 and a low price target of $5.00.
WebApr 3, 2024 · DermTech Inc. Watch list Create DMTK Alert After Hours Last Updated: Apr 3, 2024 7:41 p.m. EDT Delayed quote $ 3.8000 0.01 0.26% After Hours Volume: 195 Advanced Charting Volume: 444.47K 65 Day... WebApr 10, 2024 · DermTech, Inc. (DMTK) Reports Q4 Loss, Tops Revenue Estimates. DermTech, Inc. (DMTK) delivered earnings and revenue surprises of 3.12% and 19.52%, …
WebApr 6, 2024 · DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to aid in the diagnosis and management of various skin conditions, including skin cancer and inflammatory diseases in the United States. About the company Rewards Revenue is forecast to grow 32.61% per year Risk Analysis moxesh zotahealthcare.comWebJul 12, 2024 · DMTK Competitors. News Profile Analyst Coverage 5 Yr. Financials Dividends Adv. Charts Earnings Options Price History Events Insiders. DermTech Inc … moxehealth.com linkedinWebJan 23, 2024 · DermTech Inc ( DMTK) is near the top in its sector according to InvestorsObserver . DMTK gets an overall rating of 67. That means it scores higher than 67% of stocks. DermTech Inc gets a 86 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors. DMTK has an Overall Score of 67. moxe hand sanitizersWebApr 11, 2024 · Company Profile DMTK. DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non … moxe eucalyptus and mint hand sanitizerWebDermTech, Inc. engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. moxe hand sanitizers costcoWebApr 6, 2024 · DMTK Earnings Date and Information. DermTech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is … moxe shower sprayWebNov 2, 2024 · DermTech, Inc. (DMTK) Reports Q1 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on May 13,2024. DermTech, Inc. (DMTK) delivered earnings and revenue surprises of -4.26% and 26.20 ... moxe premium hand sanitizer